MEETING BY TELECONFERENCE
WEDNESDAY, MARCH 6, 2002
Questions
for the Committee
Session 1:
1.
What strain
should be recommended for the Influenza B component of the 2002-2003
Vaccine?
Session
2:
2.
Do you concur with the recommendations of the Site Visit Team?
If not why?